Myelofibrosis with massive hepatosplenomegaly and osteolytic bone lesions
โ Scribed by Ginger M. Merry; Paul B. Aronowitz
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 126 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1553-5592
- DOI
- 10.1002/jhm.459
No coin nor oath required. For personal study only.
โฆ Synopsis
An 83-year-old man with a 7-year history of myelofibrosis presented to the hospital with progressive weakness and fatigue, which resulted in him tripping and falling onto his left hand and arm 1 day prior to admission. His past medical history was significant for transfusion-dependent anemia and hypertension. His current treatment regimen for myelofibrosis included thalidomide and darbopoetin alfa.
Physical examination revealed a pale and edematous man who was holding his injured arm to his chest, but in no distress. He had massive hepatosplenomegaly (Figure 1
๐ SIMILAR VOLUMES
Case report: A 52 year old African American woman with a history of pulmonary sarcoidosis and non-compliance with her medical management presents to the otolaryngology clinic complaining of nasal obstruction, crusting, and epistaxis. On exam she had significant nasal crusting, friable mucosa with a
## Abstract ## BACKGROUND Treatment with zoledronic acid (Zol) was compared with a dose of 90 mg of pamidronate (Pam) in breast carcinoma (BC) patients with at least 1 osteolytic lesion based on data from a Phase III, randomized trial. ## METHODS Overall, 1130 patients with breast carcinoma who